The Korean Journal of Helicobacter and Upper Gastrointestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication

Jin Hee Noh, Kee Don Choi

Korean J Helicobacter Up Gastrointest Res. 2023;23(3):228-230. Published online September 8, 2023
DOI: https://doi.org/10.7704/kjhugr.2023.0022

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication

Jin Hee Noh, Kee Don Choi

The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2023;23(3):228-230

Link1

Link2 Link3

Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy

Kousaku Kawashima, Shunji Ishihara, Yoshikazu Kinoshita

Digestive and Liver Disease. 2016;48(6):688-689

Link1 Link2

Vonoprazan-Based Triple Therapy as First Line Treatment for Helicobacter Pylori Eradication: A Systematic Review

Juan J. Gonzalez, Rowena Inocencio, Kavitha Kesari

Gastroenterology. 2017;152(5):S248

Link1 Link2

Mo1243 An Analysis of the High Eradication Rate for Vonoprazan-Based Triple Therapy Against Helicobacter pylori Resistant to Clarithromycin

Hidetoshi Ohta, Tamotsu Sagawa

Gastroenterology. 2016;150(4):S677

Link1 Link2

Su1382 INEFFECTIVENESS OF 14-DAY VONOPRAZAN-BASED DUAL THERAPY AND VONOPRAZAN-BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREA OF HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY

Likhasit Sanglutong, Natsuda Aumpan, Bubpha Pornthisarn, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Patommatat Bhanthumkomol, Amornnivit Kanokwanvimol, Pongjarat Nunanan, Varocha Mahachai, Ratha-Korn Vilaichone

Gastroenterology. 2020;158(6):S-571

Link1 Link2

Efficacy and Safety of Vonoprazan-Based Triple Eradication Therapy for Helicobacter Pylori Infection in 890 Patients

Taro Akashi, Daisuke Fukuda, Yutaka Fukuda, Yuko Akazawa, Kazuhiko Nakao

Gastroenterology. 2017;152(5):S249-S250

Link1 Link2

Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis

Zheyu Wang, Fen Wang

Therapeutic Advances in Gastroenterology. 2022;15:175628482211253

Link1 Link2 Link3

Letter: promising results of Helicobacter pylori eradication with vonoprazan‐based triple therapy after failure of proton pump inhibitor‐based triple therapy

T. Inaba, M. Iwamuro, T. Toyokawa, H. Okada

Alimentary Pharmacology & Therapeutics. 2015;43(1):179-180

Link1 Link2

Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication

Bardhan, Morton, Slater, Perry, Cherian, Jones, Brookes, Thompson, Morris, McCaldin

Alimentary Pharmacology & Therapeutics. 1998;12(2):185-189

Link1 Link2 Link3

Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy forHelicobacter pyloriinfection: Patients' compliance and bacterial eradication rates

Halil Rakici, Remzi Adnan Akdoğan, Recep Bedir, Aysegul Copur, Arif Yilmaz

Journal of Digestive Diseases. 2014;15(9):508-513

Link1